tudy of the Prognostic Value of Neutrophil–Lymphocyte Ratio in the Early Outcome of Myocardial Infarction
International Journal of Current Pharmaceutical Review and Research · 30.07.2026 · 18 (07)
DOI: 10.25258/ijcpr.18.7.121 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.07.2026. Verfasst von Dharmendra Kanwaria und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Myocardial infarction (MI) remains a leading cause of morbidity and mortality worldwide. While various clinical markers and risk scores exist for early prognostication, emerging evidence highlights the importance of inflammatory markers in predicting adverse outcomes. The neutrophil–lymphocyte ratio (NLR), a simple and cost-effective hematological index, has gained increasing attention as a potential prognostic indicator for cardiovascular events. However, definitive data regarding its utility in early risk stratification following an acute MI remain limited.
Methods
This prospective observational study included 120 adult patients diagnosed with acute MI (STelevation or non-ST-elevation) and admitted to a tertiary care center. Blood samples were collected on admission to evaluate complete blood counts and calculate the NLR. Relevant clinical data, including demographics, risk factors, and echocardiographic parameters, were recorded. Patients were categorized into quartiles based on their admission NLR. The primary outcome was a composite of major adverse cardiac events (MACE) within 30 days, including mortality, recurrent MI, and acute heart failure. Secondary outcomes included length of hospital stay and left ventricular ejection fraction (LVEF) at discharge. Logistic regression analyses were performed to ascertain the independent prognostic value of NLR.
Results
A higher NLR on admission was significantly associated with increased rates of MACE (p < 0.001). Patients in the highest NLR quartile demonstrated a greater incidence of mortality and heart failure compared to those in the lower quartiles. Multivariate regression identified elevated NLR as an independent predictor of early adverse outcomes after adjusting for established risk factors such as age, Killip class, and left ventricular systolic function.
Conclusion
These findings suggest that admission NLR is a valuable, non-invasive prognostic biomarker for early risk stratification in patients with acute MI. Incorporating NLR into existing clinical assessment may enhance decision-making and potentially improve outcomes.
Zitieren
APA
Kanwaria, D., Kumar, P., & Verma, G. (2026). tudy of the Prognostic Value of Neutrophil–Lymphocyte Ratio in the Early Outcome of Myocardial Infarction. International Journal of Current Pharmaceutical Review and Research, 18(07). https://doi.org/10.25258/ijcpr.18.7.121
Vancouver
Kanwaria D, Kumar P, Verma G. tudy of the Prognostic Value of Neutrophil–Lymphocyte Ratio in the Early Outcome of Myocardial Infarction. International Journal of Current Pharmaceutical Review and Research. 2026;18(07). doi:10.25258/ijcpr.18.7.121
BibTeX
@article{Kanwaria2026,
author = {Kanwaria, Dharmendra and Kumar, Pradeep and Verma, Gaurav},
title = {tudy of the Prognostic Value of Neutrophil–Lymphocyte Ratio in the Early Outcome of Myocardial Infarction},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {07},
doi = {10.25258/ijcpr.18.7.121}
}
EUVIMED